GridAI Technologies (GRDX) vs Impact BioMedical (IBO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
GridAI Technologies (GRDX) has outperformed Impact BioMedical (IBO) over the past year, gaining 20.0% versus a loss of 47.4%. Impact BioMedical is the larger company by market cap ($35.1 million vs $34.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRDX | IBO |
|---|---|---|
| Share price | $4.80 | $4.11 |
| Market cap | $34.23M | $35.11M |
| 1-day change | +16.50% | -8.26% |
| YTD return | +3.00% | -35.70% |
| 1-year return | +20.00% | -47.38% |
| 5-year return | -99.99% | — |
| P/E ratio (TTM) | — | 0.37 |
| EPS (TTM) | $-5.65 | $11.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.93 | $10.51 |
| 52-week low | $1.87 | $4.10 |
| Distance from 52-week high | -30.73% | -60.88% |
| Average volume | 104.68K | 11.61K |
| Shares outstanding | 7.13M | 8.54M |
| Employees | — | 2 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GRDX has outperformed IBO by 67.4 percentage points over the past year.
About GridAI Technologies
GRDX stock →GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency.
Healthcare · Biotechnology
About Impact BioMedical
IBO stock →Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.
Healthcare · Biotechnology · 2 employees
GRDX vs IBO FAQ
Which is bigger, GridAI Technologies or Impact BioMedical?
Impact BioMedical (IBO) is larger, with a market capitalization of $35.11M compared with $34.23M for GridAI Technologies (GRDX).
Which stock has performed better over the past year, GRDX or IBO?
GRDX returned +20.00% over the past 12 months, compared with -47.38% for IBO (price return, excluding dividends). Past performance does not predict future results.
Are GridAI Technologies and Impact BioMedical in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.